Age- and gender-specific associations of napping duration with type 2 diabetes mellitus in a Chinese rural population: the RuralDiab study

2017 ◽  
Vol 33 ◽  
pp. 119-124 ◽  
Author(s):  
Ruihua Liu ◽  
Yuqian Li ◽  
Fang Wang ◽  
Xiaotian Liu ◽  
Hao Zhou ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Rural Population ◽  
Age And Gender ◽  
And Gender ◽  
Gender Specific

scholarly journals Impact of Hypertension on the Association of BMI with Risk and Age at Onset of Type 2 Diabetes Mellitus: Age- and Gender-Mediated Modifications

PLoS ONE ◽  
2014 ◽  
Vol 9 (4) ◽  
pp. e95308 ◽  
Author(s):  
Arshad Mohamed Channanath ◽  
Bassam Farran ◽  
Kazem Behbehani ◽  
Thangavel Alphonse Thanaraj
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Age At Onset ◽  
Age And Gender ◽  
And Gender

scholarly journals PROFIL LIPID PENDERITA DIABETES MELLITUS TIPE 2 P

2018 ◽  
Vol 13 (1) ◽  
pp. 20
Author(s):  
S Josten ◽  
Mutmainnah . ◽  
Hardjoeno .
Keyword(s):  
Internal Medicine ◽  
Diabetes Mellitus ◽  
Risk Factors ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Age Group ◽  
Age And Gender ◽  
Type 2 Dm ◽  
And Gender

Prevalence of type 2 diabetes mellitus (DM) tends to increasing worldwide. The main cause of death in type 2 DM is coronaryheart disease (CHD) and its mortality rate can increase 2 to 4 times compared to non-diabetics. One of the risk factors in CHD isdyslipidemia. To know the lipid profile based on age and gender and to assess the relation of total cholesterol, LDL, HDL, and TG levelto age. Descriptive retrospective study in patients with type 2 DM who are 45 years old and over. From 100 Type 2 DM patients, in theDepartment of Internal Medicine, Dr. Wahidin Sudirohusodo Hospital, Makassar, period of June to December 2005, the largest age groupwith dyslipidemia was > 59 years old, with increase LDL level, 32.73% in males and 46.67% in females. There was a significant relationbetween the in crease of TG (p = 0.03) and the decrease of HDL (p = 0.02) with age. Dyslipidemia in type 2 DM patients at age group> 59 years old was shown by an increase in LDL level. The increase of TG and decrease of HDL level were significant in all age groups.Restriction of this study was not to check the antilipidemic medicine used. Early dyslipidemia of Type 2 DM should be known by lipidfraction determination and further dyslipidemia study should be conducted to predict the risk of CHD.

Type 2 diabetes mellitus and gender-specific risk for colorectal neoplasia

2012 ◽  
Vol 27 (5) ◽  
pp. 341-347 ◽  
Author(s):  
Heike Ursula Krämer ◽  
Heiko Müller ◽  
Christa Stegmaier ◽  
Dietrich Rothenbacher ◽  
Elke Raum ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Colorectal Neoplasia ◽  
Specific Risk ◽  
And Gender ◽  
Gender Specific

Abstract P440: Ethnic and Gender-specific Prevalence of Type 2 Diabetes Mellitus among Adults in the California Health Interview Survey 2009

Circulation ◽  
2013 ◽  
Vol 127 (suppl_12) ◽  
Author(s):  
Sarah Choi ◽  
Michael Liu ◽  
Latha Palaniappan ◽  
Elsie Wang ◽  
Nathan Wong
Keyword(s):  
Diabetes Mellitus ◽  
Risk Factors ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
California Health Interview Survey ◽  
Health Interview Survey ◽  
Interview Survey ◽  
And Gender ◽  
Gender Specific

Background: The ethnic and gender-specific prevalence of type 2 diabetes mellitus (DM) have not been adequately documented in past studies; in addition, Asians and Hispanics have been often treated as aggregates, making it difficult to examine subgroup differences. Methods: Using the California Health Interview Survey (CHIS) 2009 data, we identified the prevalence of DM and associated risk factors, stratified by gender, for the following ethnicities: Chinese, Filipino, South Asian, Japanese, Korean, Vietnamese, Cambodian, Mexican, Hispanic (Other), African American, and Caucasian (n=45,857, projected = 26.6 mil). Results: Among men, the age-adjusted prevalence of DM was highest in Filipinos (15.8%), Japanese (11.8%), and Mexicans (10.2%). Among women, African Americans (13.3%) and Other Hispanic (10.7%) had the highest DM prevalence. Significant gender difference was observed in Caucasians and Mexicans, where men had a higher DM prevalence than women. In multiple logistic regression adjusting for age and other clinical and lifestyle risk factors, among women, compared to Caucasians, an increased likelihood of DM was seen in Koreans (OR=4.72, p <0.01), Cambodian (OR=3.84, p <0.05), and Other Hispanic (OR=2.90, p <0.01) Among men, compared to Caucasians, DM was more likely in Filipinos (OR=6.99, p <0.01), South Asians (OR=4.69, p <0.01), and Mexicans (OR=2.82, p <0.01). Conclusion: Ethnic and gender differences in DM prevalence persist, even after adjusting for lifestyle and other risk factors. Racial/ethnic minority groups, particularly certain Asian subgroups, have the highest DM prevalence in California, despite risk factor adjustment. Different ethnic and gender- specific diabetes prevention approaches may be required.

Type-2 diabetes mellitus in schizophrenia: Increased prevalence and major risk factor of excess mortality in a naturalistic 7-year follow-up

2012 ◽  
Vol 27 (1) ◽  
pp. 33-42 ◽  
Author(s):  
D. Schoepf ◽  
R. Potluri ◽  
H. Uppal ◽  
A. Natalwala ◽  
P. Narendran ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Excess Mortality ◽  
Age And Gender ◽  
Predictors Of Mortality ◽  
Co Morbidity ◽  
And Gender ◽  
The Impact

AbstractObjectivePhysical co-morbidity including type 2 diabetes mellitus is more prevalent in patients with schizophrenia compared to the general population. However, there is little consistent evidence that co-morbidity with diabetes mellitus and/or other diseases leads to excess mortality in schizophrenia. Thus, we investigated whether co-morbidity with diabetes and other somatic diseases is increased in schizophrenics, and if these are equally or more relevant predictors of mortality in schizophrenia than in age- and gender-matched hospitalised controls.MethodsDuring 2000–2007, 679 patients with schizophrenia were admitted to University Hospital Birmingham NHS Trust. Co-morbidities were compared with 88,778 age- and gender group-matched hospital controls. Predictors of mortality were identified using forward Cox regression models.ResultsThe prevalence of type 2 diabetes mellitus was increased in schizophrenia compared to hospitalised controls (11.3% versus 6.3%). The initial prevalence of type 2 diabetes mellitus was significantly higher in the 100 later deceased schizophrenic patients (24.0%) than in those 579 surviving over 7 years (9.2%). Predictors of mortality in schizophrenia were found to be age (relative risk [RR] = 1.1/year), type 2 diabetes mellitus (RR = 2.2), pneumonia (RR = 2.7), heart failure (RR = 2.9) and chronic renal failure (RR = 3.2). The impact of diabetes mellitus on mortality was significantly higher in schizophrenia than in hospital controls (RR = 2.2 versus RR = 1.1). In agreement, deceased schizophrenics had significantly suffered more diabetes mellitus than deceased controls (24.0 versus 10.5%). The relative risks of mortality for other disorders and their prevalence in later deceased subjects did not significantly differ between schizophrenia and controls.ConclusionSchizophrenics have more and additionally suffer more from diabetes: co-morbidity with diabetes mellitus is increased in schizophrenia in comparison with hospital controls; type 2 diabetes mellitus causes significant excess mortality in schizophrenia. Thus, monitoring for and prevention of type 2 diabetes mellitus is of utmost relevance in hospitalised patients with schizophrenia.

Impact on Diabetes Mellitus on the Epicardial Coronary Flow Velocity Assessed by the Thrombolysis in Myocardial Infarction Frame Count

Angiology ◽  
2008 ◽  
Vol 60 (4) ◽  
pp. 431-440 ◽  
Author(s):  
Ahmet Soylu ◽  
Kurtulus Ozdemir ◽  
Mehmet Akif Duzenli ◽  
Mehmet Yazici ◽  
Mehmet Tokac
Keyword(s):  
Diabetes Mellitus ◽  
Myocardial Infarction ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Flow Velocity ◽  
Coronary Arteries ◽  
Coronary Flow ◽  
Coronary Flow Velocity ◽  
And Gender

The aim of this study is to evaluate the effect of type 2 diabetes mellitus on epicardial coronary flow velocity assessed by the thrombolysis in myocardial infarction frame count. The thrombolysis in myocardial infarction frame count was measured in 272 coronary arteries from 101 patients with type 2 diabetes mellitus and in 271 coronary arteries from 104 age- and gender-matched patients without type 2 diabetes mellitus referred for coronary angiography. The thrombolysis in myocardial infarction frame count was measured only in normal arteries or in arteries without significant lesion. By both univariate and multivariate analysis, the thrombolysis in myocardial infarction frame count was not related with either type 2 diabetes mellitus or the duration and glycated hemoglobin levels in the patients with type 2 diabetes mellitus. The thrombolysis in myocardial infarction frame count was significantly associated with body surface area, heart rate, and proximal coronary artery diameter. Type 2 diabetes mellitus did not affect epicardial coronary flow velocity assessed by the thrombolysis in myocardial infarction frame count.

Sign in / Sign up

Export Citation Format

Share Document